NCT01301417

Brief Summary

The proposed study is a post marketing, observational, retrospective data collection intended to gather and record data on patients treated with the ColonRing™ device in routine clinical practice at a single center. The data will assist in further evaluating the performance of the ColonRing™ device in regards to the creation of a colorectal anastomosis. Hypothesis:The performance of the ColonRing™, determined by the rate of complications, will be within the acceptable range reported in the literature for alternative treatment modalities.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
171

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2011

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
19 days until next milestone

First Submitted

Initial submission to the registry

February 20, 2011

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 23, 2011

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

June 5, 2013

Status Verified

June 1, 2013

Enrollment Period

6 months

First QC Date

February 20, 2011

Last Update Submit

June 4, 2013

Conditions

Keywords

Compression Anastomosis

Outcome Measures

Primary Outcomes (1)

  • Rate of anastomotic leakage

    The primary study outcome is the rate of anastomotic leakage. Anastomotic leakage is defined as evidence of a defect in the intestinal wall integrity at the anastomotic site leading to a communication between the intra and extra luminal compartments.

    2-mo post-op

Secondary Outcomes (1)

  • Rate of other device related complications and measures during hospitalization and post procedure:

    2-mo post-op

Study Arms (1)

ColonRing™

Adult Patients who underwent a laparoscopic or open colorectal resection with the creation of an anastomosis using the ColonRing™ in routine clinical practice

Device: ColonRing™

Interventions

Creation of a circular Compression Anastomosis

Also known as: Compression Anaqstomosis Ring™(CAR™)27
ColonRing™

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult Patients who underwent a laparoscopic or open colorectal resection with the creation of an anastomosis using the ColonRing™ in routine clinical practice.

You may qualify if:

  • Patient was \> 18 years old at time of procedure
  • Patient underwent an open or laparoscopic colorectal procedure with the creation of an anastomosis using the ColonRing™
  • Patient treated in routine clinical practice following marketing clearance of the device within the cleared intended use
  • Patient underwent his/her first follow-up visit within two months post-surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southern Regional Medical Center

Riverdale, Georgia, 30274, United States

Location

MeSH Terms

Conditions

Diverticulum, ColonColorectal NeoplasmsCrohn DiseaseColitis, UlcerativeRectal ProlapseIntestinal PolyposisLymphomaEndometriosisIntestinal Volvulus

Condition Hierarchy (Ancestors)

DiverticulumDiverticular DiseasesGastroenteritisGastrointestinal DiseasesDigestive System DiseasesPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsColonic DiseasesIntestinal DiseasesRectal DiseasesInflammatory Bowel DiseasesColitisPelvic Organ ProlapseProlapseNeoplasms by Histologic TypeLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesIntestinal ObstructionTorsion Abnormality

Study Officials

  • Eran Choman, Msc

    novoGI

    STUDY DIRECTOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 20, 2011

First Posted

February 23, 2011

Study Start

February 1, 2011

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

June 5, 2013

Record last verified: 2013-06

Locations